TRPM4 and skin disorder: Treatment with a TRPM4 inhibitor, glibenclamide, ameliorated the psoriasis induced by imiquimod in both wild-type and TRPM4I1029M mice, highlighting the potential therapeutic significance of TRPM4 targeting in the context of skin disorders.